APA

Krychtiuk K. A., Kaun C., Hohensinner P. J., Stojkovic S., Seigner J., Kastl S. P., Zuckermann A., Eppel W., Rauscher S., de Martin R., Maurer G., Huber K., Wojta J. & Speidl W. S. (20170724). Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro. : Vascular pharmacology.

Chicago

Krychtiuk Konstantin A, Kaun Christoph, Hohensinner Philipp J, Stojkovic Stefan, Seigner Jacqueline, Kastl Stefan P, Zuckermann Andreas, Eppel Wolfgang, Rauscher Sabine, de Martin Rainer, Maurer Gerald, Huber Kurt, Wojta Johann and Speidl Walter S. 20170724. Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro. : Vascular pharmacology.

Harvard

Krychtiuk K. A., Kaun C., Hohensinner P. J., Stojkovic S., Seigner J., Kastl S. P., Zuckermann A., Eppel W., Rauscher S., de Martin R., Maurer G., Huber K., Wojta J. and Speidl W. S. (20170724). Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro. : Vascular pharmacology.

MLA

Krychtiuk Konstantin A, Kaun Christoph, Hohensinner Philipp J, Stojkovic Stefan, Seigner Jacqueline, Kastl Stefan P, Zuckermann Andreas, Eppel Wolfgang, Rauscher Sabine, de Martin Rainer, Maurer Gerald, Huber Kurt, Wojta Johann and Speidl Walter S. Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro. : Vascular pharmacology. 20170724.